Risk Assessment
Watch the DPNCheck Overview

product img 1


DPNCheck can improve the effectiveness of neuropathy detection programs and is ideal for:

  • Risk Based Organizations
  • Clinic Based Health Risk Assessments
  • Health Risk Assessment Service Providers for In-home Use

Why Use Nerve Conduction to Detect Peripheral Neuropathy?

The prevalence of peripheral neuropathy in the general population is 10% and in patients over 65 it increases up to 30%1. Over 50% of patients with diabetes will develop neuropathy2. The rate of diagnosed neuropathy is often much lower than the prevalence rate resulting in unidentified risk.

  • Traditional detection tools (monofilament or tuning fork) detect only late stage neuropathy and have low sensitivity3
  • Due to the subjective nature of these tests they are usually performed by physicians not staff
  • Compliance rates for the performance of these tests are typically poor
  • Sural nerve conduction detects peripheral neuropathy with high diagnostic sensitivity at all stages of severity
product img 1
product img 1

Benefits of Improved Peripheral Neuropathy Detection in a Managed Care Organization:

  • Accurately risk assess members
  • Early diagnosis of peripheral neuropathy presents opportunities to intervene and reduce costs
  • Identify those patients with neuropathy that are at highest risk for neuropathy related complications such as foot ulcers, neuropathic pain, and falls
  • Efficient and cost effective testing

DPNCheck Clinical Validation

DPNCheck has been clinically validated in numerous peer-reviewed journal publications and clinical conference presentations. Click here to view the complete list.

product img 1


1. Hicks, C.W., Wang, D., Windham, B.G. et al. Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci Rep; 11, 19159, (2021)

2. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154

3. Perkins, et al. Simple Screening tests for Peripheral Neuropathy in the Diabetes Clinic. Diabetes Care. 24: 250-256, 2001.